Novo Nordisk posted solid quarterly results Wednesday before the market open.Sales came in at 71.3 billion Danish crowns ($10 ...
The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose ...
Kentucky, Alaska and Alabama are the three states where weight loss drugs ... U.S. Food and Drug Administration (FDA) approved the semaglutide-based drug Wegovy for obesity. Before Wegovy, 190,000 ...
Zealand Pharma A/S said moderate doses of its experimental weight-loss drug helped patients pare pounds with less nausea than ...
Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.
Vos agrees that modelling the health effects of weight loss with GLP-1 agonists isn’t straightforward. It’s unclear, he says, ...